- Monday, September 14, 2026
- India +91 7982732466
- U.S +1 217 953 4020
- Info@Shingetsuresearch.com
Global Oncology Informatics Market- By Type (Electronic Health Records (EHRs), Population Health Management (PHM), Clinical Decision Support System (CDSS), Drug Discovery and Development Informatics), By Application (Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Others), By End Use (Pharmaceutical Industry, Life Science Industry, Contract Research Organizations (CROs), Academic Institutes and Research Centers, Others), and By Region (North America, Europe, Asia Pacific, South America, and Middle East, & Africa)- Global forecast from 2020-2027.
Global Oncology Informatics Market Overview:
Oncology informatics refers to a multidisciplinary field of science that helps in acquiring, storing, and using the information of tumor or cancer most effectively. Also, oncology informatics will help in collecting pieces of evidence that will useful for treating patients against cancer by using informatics tools.
Global Oncology Informatics Market Insights
The global oncology informatics market has the potential to grow with USD 8.24 billion with bolstering CAGR in the forecast period from 2020-2027. Due to the rising chronic diseases such as cancer and the emerging cost of cancer treatment, and also the adoption of oncology and emerging approach for reducing medical error is driving the market demand for global oncology informatics.
Pharmacology with a focus on genomics is playing an increasingly important role in cancer treatment, and next-generation sequencing (NGS) has gradually become an extraordinary method to study the molecular basis of individual tumors more in-depth and more accurately.
NGS (high-throughput sequencing) is mainly used in liquid biopsy in the oncology field and has broad application space in the early screening of cancer, personalized medicine, and prognosis markets. It is the main factor restricting its rapid commercialization, including efficient and accurate enrichment purposes gene sequence and complete deep sequencing, organ tracing, detection accuracy, and sensitivity,
Moreover, it generally believes that NGS-driven companion diagnostics can promote treatment options and improve patient outcomes in the future. Compared with traditional methods, NGS has many advantages in accuracy, sensitivity, and speed, and will have a significant impact on the field of oncology in the future. NGS can determine multiple genes in a single test without having to order various tests to identify disease-causing mutations.
Therefore, the multi-gene approach shortens the time to obtain answers, provides a more economical solution, and reduces the risk of exhausting precious clinical samples. NGS can provide high sensitivity and can detect mutations in DNA as low as 5% of tumor samples. Also, NGS has the potential to change the future of oncology and promote the development of personalized medicine.
Growth Driver
Rising patient health data
The low level of data integration leads to inefficiency, which not only causes waste and mistakes in the clinical workflow, but also causes excessive treatment, hurts patients, and also leads to cost overruns. Thus, with emerging data of patient health, it is essential to analyze it properly for providing better treatment and reduce medical costs and manual medical errors.
Emerging diagnostic methods
The prevalence of technology in the healthcare industry has improved the function and operations of the medical industry and enhance the diagnostic method for better treatment. Thus, an integrated diagnostic approach that can rely on computer tools and intuitive IT interfaces to utilize the available data sources, then the clinical path can accurately formulate and paved the way for precision medicine.
By Type Segmental Analysis
Based on the type, the global oncology informatics market segmented into Electronic Health Records (EHRs), Population Health Management (PHM), Clinical Decision Support System (CDSS), Drug Discovery and Development Informatics. The clinical decision support system segment accounted for the largest share in the global oncology informatics market. The factor driving the CDSS market is due to patient health data, which is becoming more and more abundant. It expected to achieve a personalized and efficient diagnosis and treatment decisions. The integrated decision support tool brings all this information into a unified platform, which not only simplifies the workflow but also helps doctors choose the best treatment plan for the patient’s specific situation.
By Application Segmental Analysis
Based on the application, the global oncology informatics market segmented into Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Others. Colorectal cancer dominates the most significant share for the market oncology informatics. It is mainly owing to one of the reasons for the failure of these attempts is that colorectal cancer is a highly heterogeneous disease, which includes both inter-tumor and intra-tumor levels. With the advancement of gene-proteomics technology, it has become possible to measure molecular typing of colorectal cancer from gene transcription to protein expression in a higher dimension. Thus, making it possible to depict the high heterogeneity of colorectal cancer positively.
By End-User Segmental Analysis
Based on the end-user, the global oncology informatics market classified into Pharmaceutical Industry, Life Science Industry, Contract Research Organizations (CROs), Academic Institutes and Research Centers, Others. The research centers segment has dominated the largest share in the global oncology informatics market. It mainly owes to propelling computer analysis, and modeling tools can use to integrate data in multiple formats provided by high-throughput technologies to avoid overtreatment and achieve personalized disease management. Therefore, the demand for the research centers will fuel the market demand of the global oncology informatics market.
By Region Segmental Analysis
Based on geography, the global oncology informatics market segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. Asia Pacific region is dominating the market share of the global oncology informatics market. The bolstering medical infrastructure and technology advancement in the healthcare sector and increasing investment in R&D for the development of drugs are dominating the market of the Asia Pacific region.
Competitor Analysis
Companies such as Cerner Corporation, Change Healthcare, Elekta AB, F.Hoffmann-La Roche Ltd., Hologic Inc., IBM Corporation, Inspirata Inc., Koninklijke Philips N.V., Laboratory Corporation of America Holdings, McKesson Corporation, MIM Software, Inc. Oncology Analytics, Inc., PerkinElmer, Inc., RELX Group, Sirenas LLC, UnitedHealth Group, Inc., Varian Medical Systems, Inc, and others are key players in the global oncology informatics market.
Key Stakeholders
- Market research and consulting firms
- Industry associations
- Global oncology informatics service companies
- Research organizations and consulting companies’ oncology informatics
- Regulatory bodies
The objective of the Research
- Market modeling starts with identifying a target market where historical data exists. A Market can include prediction problems, economic factors, analyzing customer behavior, and identifying new patterns from past events, which helps our client to have deep dive into the market.
- Product analysis involves steps such as examining product features, costs, availability, quality, and other aspects. Product analysis is conducted to understand potential buyers and measure competition in the market.
- Market Trend and Economic Factors Analysis helps in assessing potential changes to an economy’s inflation rate, taxes, interest rates, exchange rates, trading regulations, and excise duties that can or have a major effect on the target market.
- Market Segmental Analysis defines in-depth scenario of the target market by the process of grouping consumers into naturally existing created segments of consumers who share similar product preferences or characteristics
- The geographical mapping approach helps our clients to understand national or international markets because different consumers in different regions have different needs wants, and cultural characteristics that can be specifically targeted.
Market Modelling
By Type
- Electronic Health Records (EHRs)
- Population Health Management (PHM)
- Clinical Decision Support System (CDSS)
- Drug Discovery and Development Informatics
By Application
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Cervical Cancer
- Others
By End-User
- Pharmaceutical Industry
- Life Science Industry
- Contract Research Organizations (CROs)
- Academic Institutes and Research Centers
- Others (Hospitals and Other Care Facilities)
By Region
- Europe
- North America
- Asia Pacific
- South America
- Middle East & Africa
Global Oncology Informatics Market
Report Content
- Research Strategic Development
- Market Modelling
- Product Analysis
- Market Trend and Economic Factors Analysis
- Market Segmental Analysis
- Geographical Mapping
- Country Wise Segregation
- Research Methodology
- Identification of Target Market
- Data Acquisition
- Refining of Data/ Data Transformations
- Data Validation through Primary Techniques
- Exploratory Data Analysis
- Graphical Techniques/Analysis
- Quantitative Techniques/Analysis
- Visual Result/Presentation
- Executive Summary
- Market Insights
- Economic Factor Analysis
- Drivers
- Trends
- Opportunities
- Challenges
- Competitors & Product Analysis
- Regulatory Framework
- Company market share analysis, 2019
- Porter’s Five forces analysis
- New Investment Analysis
- PESTEL Analysis
- Economic Factor Analysis
- Global Oncology Informatics Market Overview
- Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Market Share & Forecast, 2016-2027
- By Type
- Electronic Health Records (EHRs)
- Population Health Management (PHM)
- Clinical Decision Support System (CDSS)
- Drug Discovery and Development Informatics
- By Application
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Cervical Cancer
- Others
- By End-User
- Pharmaceutical Industry
- Life Science Industry
- Contract Research Organizations (CROs)
- Academic Institutes and Research Centers
- Others (Hospitals and Other Care Facilities)
- By Region
- Europe
- North America
- Asia Pacific
- South America
- Middle East & Africa
- By Type
- Demand
- Market Size & Forecast, 2016-2027
- Europe Oncology Informatics Market Overview
- Europe Oncology Informatics Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Europe Oncology Informatics Market Share & Forecast, 2016-2027
- By Type
- Electronic Health Records (EHRs)
- Population Health Management (PHM)
- Clinical Decision Support System (CDSS)
- Drug Discovery and Development Informatics
- By Application
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Cervical Cancer
- Others
- By End-User
- Pharmaceutical Industry
- Life Science Industry
- Contract Research Organizations (CROs)
- Academic Institutes and Research Centers
- Others (Hospitals and Other Care Facilities)
- By Country
- Germany
- UK
- France
- Italy
- Rest of Europe
- Company Market Share (Top 3-5)
- Economic Impact Study on Europe Oncology Informatics Market
- By Type
- Demand
- Europe Oncology Informatics Market Size & Forecast, 2016-2027
- North Oncology Informatics Market Overview
- North America Oncology Informatics Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- North America Oncology Informatics Market Share & Forecast, 2016-2027
- By Type
- Electronic Health Records (EHRs)
- Population Health Management (PHM)
- Clinical Decision Support System (CDSS)
- Drug Discovery and Development Informatics
- By Application
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Cervical Cancer
- Others
- By End-User
- Pharmaceutical Industry
- Life Science Industry
- Contract Research Organizations (CROs)
- Academic Institutes and Research Centers
- Others (Hospitals and Other Care Facilities)
- By Country
- US
- Canada
- Mexico
- Company Market Share (Top 3-5)
- Economic Impact Study on North America Oncology Informatics Market
- By Type
- Demand
- North America Oncology Informatics Market Size & Forecast, 2016-2027
- Asia Pacific Oncology Informatics Market Overview
- Asia Pacific Oncology Informatics Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Asia Pacific Oncology Informatics Market Share & Forecast, 2016-2027
- By Type
- Electronic Health Records (EHRs)
- Population Health Management (PHM)
- Clinical Decision Support System (CDSS)
- Drug Discovery and Development Informatics
- By Application
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Cervical Cancer
- Others
- By End-User
- Pharmaceutical Industry
- Life Science Industry
- Contract Research Organizations (CROs)
- Academic Institutes and Research Centers
- Others (Hospitals and Other Care Facilities)
- By Country
- China
- India
- Japan
- Australia
- Rest of Asia Pacific
- Company Market Share (Top 3-5)
- Economic Impact Study on Asia Pacific Oncology Informatics Market
- By Type
- Demand
- Asia Pacific Oncology Informatics Market Size & Forecast, 2016-2027
- South America Oncology Informatics Market Overview
- South America Oncology Informatics Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- South America Oncology Informatics Market Share & Forecast, 2016-2027
- By Type
- Electronic Health Records (EHRs)
- Population Health Management (PHM)
- Clinical Decision Support System (CDSS)
- Drug Discovery and Development Informatics
- By Application
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Cervical Cancer
- Others
- By End-User
- Pharmaceutical Industry
- Life Science Industry
- Contract Research Organizations (CROs)
- Academic Institutes and Research Centers
- Others (Hospitals and Other Care Facilities)
- By Country
- Brazil
- Argentina
- Rest of South America
- Company Market Share (Top 3-5)
- Economic Impact Study on South America Oncology Informatics Market
- By Type
- Demand
- South America Oncology Informatics Market Size & Forecast, 2016-2027
- Middle East & Africa Oncology Informatics Market Overview
- Middle East & Africa Oncology Informatics Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Middle East & Africa Oncology Informatics Market Share & Forecast, 2016-2027
- By Type
- Electronic Health Records (EHRs)
- Population Health Management (PHM)
- Clinical Decision Support System (CDSS)
- Drug Discovery and Development Informatics
- By Application
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Cervical Cancer
- Others
- By End-User
- Pharmaceutical Industry
- Life Science Industry
- Contract Research Organizations (CROs)
- Academic Institutes and Research Centers
- Others (Hospitals and Other Care Facilities)
- By Country
- Saudi Arabia
- UAE
- South Africa
- Rest of Middle East & Africa
- Company Market Share (Top 3-5)
- Economic Impact Study on Middle East & Africa Oncology Informatics Market
- By Type
- Demand
- Middle East & Africa Oncology Informatics Market Size & Forecast, 2016-2027
- Competitor Analysis
- Company Description
- Financial Analysis
- Key Products
- Key Management Personnel
- Contact Address
- SWOT Analysis
- Company Profile
- Cerner Corporation
- Change Healthcare
- Elekta AB
- Hoffmann-La Roche Ltd.
- Hologic Inc.
- IBM Corporation
- Inspirata Inc.
- Koninklijke Philips N.V.
- Laboratory Corporation of America Holdings
- McKesson Corporation
- MIM Software, Inc.
- Oncology Analytics, Inc.
- PerkinElmer, Inc.
- RELX Group
- Sirenas LLC
- UnitedHealth Group, Inc.
- Varian Medical Systems, Inc
- Other players
